Israel - English - Ministry of Health

novartis israel ltd - rivastigmine as hydrogen tartrate - capsules - rivastigmine as hydrogen tartrate 1.5 mg - rivastigmine - rivastigmine - treatment of patients with mild to moderately severe dementia of the alzheimer type, also termed probable alzheimer's disease or alzheimer's disease.symptomatic treatment of mild to moderately severe alzheimer's dementia.symptomatic treatment of mild to moderately severe dementia associated with parkinson's disease.

Israel - English - Ministry of Health

novartis israel ltd - rivastigmine as hydrogen tartrate - capsules - rivastigmine as hydrogen tartrate 3 mg - rivastigmine - rivastigmine - treatment of patients with mild to moderately severe dementia of the alzheimer type, also termed probable alzheimer's disease or alzheimer's disease.symptomatic treatment of mild to moderately severe alzheimer's dementia.symptomatic treatment of mild to moderately severe dementia associated with parkinson's disease.

Israel - English - Ministry of Health

novartis israel ltd - rivastigmine as hydrogen tartrate - capsules - rivastigmine as hydrogen tartrate 4.5 mg - rivastigmine - rivastigmine - treatment of patients with mild to moderately severe dementia of the alzheimer type, also termed probable alzheimer's disease or alzheimer's disease.symptomatic treatment of mild to moderately severe alzheimer's dementiasymptomatic treatment of mild to moderately severe dementia associated with parkinson's disease.

Israel - English - Ministry of Health

novartis israel ltd - rivastigmine as hydrogen tartrate - capsules - rivastigmine as hydrogen tartrate 6 mg - rivastigmine - rivastigmine - treatment of patients with mild to moderately severe dementia of the alzheimer type, also termed probable alzheimer's disease or alzheimer's disease.symptomatic treatment of mild to moderately severe alzheimer's dementia.symptomatic treatment of mild to moderately severe dementia associated with parkinson's disease.

Israel - English - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - eletriptan hydrobromide - film coated tablets - eletriptan hydrobromide 24.242 mg - eletriptan - acute treatment of the headache phase of migraine attacks, with or without aura.

Israel - English - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - eletriptan hydrobromide - film coated tablets - eletriptan hydrobromide 48.485 mg - eletriptan - acute treatment of the headache phase of migraine attacks, with or without aura.

Israel - English - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - eletriptan hydrobromide - film coated tablets - eletriptan hydrobromide 96.97 mg - eletriptan - acute treatment of the headache phase of migraine attacks, with or without aura.

Israel - English - Ministry of Health

cts chemical industries ltd, israel - selegiline hydrochloride - tablets - selegiline hydrochloride 5 mg - selegiline - selegiline - treatment of parkinson's disease or symptomatic parkinsonism.

Israel - English - Ministry of Health

astrazeneca (israel) ltd - gefitinib - film coated tablets - gefitinib 250 mg - gefitinib - gefitinib - iressa is indicated for the treatment of adult patients with locally advanced or metastatic non-small cell lung cancer (nsclc) with activating mutations of egfr-tk.

Israel - English - Ministry of Health

astrazeneca (israel) ltd - quetiapine as fumarate - tablets prolonged release - quetiapine as fumarate 150 mg - quetiapine - seroquel xr is indicated for the treatment of schizophrenia. seroquel xr is effective in preventing relapse in stable schizophrenic patients who have been maintained on seroquel xr. seroquel xr is indicated for the treatment of moderate to severe manic episodes associated with bipolar disorder.seroquel xr is indicated for the treatment of major depressive episodes in bipolar disorder. treatment of acute mania associated with bipolar i disorder as monotherapy or in combination with lithium or sodium valproate.seroquel xr is indicated for preventing recurrence in bipolar disorder in patients whose manic, mixed or depressive episode has responded to quetiapine treatment, as monotherapy or in combination with lithium or sodium valproate.seroquel xr is indicated for add-on treatment of major depressive episods in patients with major depressive disorder (mdd) who have had sub-optimal response to antidepressant monotherapy (see section 5.1 pharmacodynamic properties). prior to initiating treatment, clinicians shoul